SlideShare une entreprise Scribd logo
1  sur  22
Télécharger pour lire hors ligne
CORONARY: The Coronary Artery Bypass
   Grafting Surgery Off or On Pump
       Revascularization Study

                    Results at 1 Year
                                 André Lamy
                        Population Health Research Institute
                             Hamilton Health Sciences
                               McMaster University
                                Hamilton, CANADA

              on behalf of the CORONARY Investigators

    Disclosures: CORONARY was funded by a grant from the Canadian Institutes
                            of Health Research (CIHR).
Background

• Benefits and risks of performing CABG surgery on
  beating heart (off pump) not clearly established.
• Meta-analyses of 59 trials involving 8961 pts
  – No differences in major CV outcomes except strokes
• ROOBY (1 Year)
  – Primary Outcome: Off-pump is worse (p=0.04)
  – CV Deaths: Off-pump is worse (p=0.03)


                                                         2
CORONARY Trial Organization
• 79 centers in 19 countries
• 4,752 patients recruited between (November 2006
  October 2011)
• Designed, coordinated, managed and data analysed
  and reported by the Population Health Research
  Institute, Hamilton Health Sciences and McMaster
  University in Hamilton, Canada
• The data was monitored by independent DSMB
• Funded by Canadian Institutes of Health Research

                                                     3
Inclusion/Exclusion Criteria
• Inclusion Criteria
   – Isolated CABG with median sternotomy
   – One of the following:
       1.   Peripheral vascular disease
       2.   Cerebrovascular disease
       3.   Renal Insufficiency
       4.   Age ≥ 70 years
       5.   Age 60 -69 with at least one risk factor (diabetes, urgent
            revascularization, smoker, LVEF ≤ 35%)
       6.   Age 55 -59 with at least two of the above risk factors
• Exclusions
   – Additional cardiac procedure planned
   – Contraindications to off-pump or on-pump CABG
   – Emergency or re-do CABG
                                                                         5
Qualifications of Surgeons
• Surgical expertise-based randomization

  – > 2 years of experience as staff cardiac surgeon
                 and
  – > 100 cases of one or both techniques

  – Trainees were not allowed to be primary
    operators

                                                       6
Primary Outcomes
• 1st Co-Primary Outcome
  Composite of total mortality, stroke, non fatal myocardial
  infarction, new renal failure at 30 days post randomization
                   results presented ACC 2012
                   results at 1 year

• 2nd Co-Primary Outcome
  Composite of above outcomes plus repeat coronary
  revascularization over 5 yrs of follow-up (expected 2016)

                                                                7
Baseline Characteristics
                                 OFF-PUMP     ON-PUMP
                                 (n = 2375)   (n = 2377)
Mean Age (years)                    67.6        67.5

Males (%)                           80.0        81.7
Prior MI                            33.8        35.2

Previous Stroke                     6.7          7.8

Peripheral Arterial Disease         8.0          8.2

Congestive Heart Failure            5.9          6.6
Urgent Surgery                      39.5        38.1

Euroscore
   0–2                              28.6        27.8
   3–5                              51.7        54.2
   > 5                              18.1        16.8
                                                           10
Baseline Disease – Pre-op Angiogram

                       OFF-PUMP     ON-PUMP
                       (n = 2375)   (n = 2377)
                            %            %

Left Main                 22.1        20.9

Triple Vessel             56.1        60.4

Double Vessel             18.7        16.4

Single Vessel             3.0          2.1




                                                 11
1st Co-Primary Outcome (1 Year)
                                   Off Pump On Pump   Hazard                 p
                                       %       %       Ratio    95% CI     value
Primary Outcome
                                    12.1     13.3      0.91    0.77-1.07   0.24
Death, Stroke, MI, Renal Failure
Components

   Death                             5.1      5.0      1.03    0.80-1.32

   Stroke                            1.5      1.7      0.90    0.57-1.41

   Non Fatal MI                      6.8      7.5      0.90    0.73-1.12

   New Renal Failure                 1.3      1.3      0.97    0.59-1.60




                                                                                   14
Death/MI/Stroke/New Renal Failure
                        0.20
                        0.15          at 1 Year


                                         On Pump CABG
Cumulative Event Rate




                                         Off Pump CABG
                        0.10




                                             HR 0.91
                        0.05




                                             95% CI 0.77-1.07
                                             p value 0.24
                        0.0




                               0   3     6               9      12

                                                                     15
Other Outcomes at 1 year
                               Off Pump On Pump   Hazard
                                                            95% CI     p value
                                   %       %       Ratio

Cardiovascular Mortality         4.2      4.0      1.03    0.78-1.37    0.83

Angina                           1.0      0.9      1.05    0.58-1.88    0.87

PCI                              1.1      0.8      1.43    0.79-2.57    0.23

Re-do CABG                       0.3     0.04      7.00    0.86-57.0    0.07

PCI/Re-do CABG                   1.4      0.8      1.66    0.95-2.89    0.07

Primary Outcome per Protocol     11.5    13.2      0.86    0.73-1.02    0.08



                                                                               16
Primary Outcome between
                     31 days and 1 Year
                                Off Pump On Pump Hazard                 p
                                    %       %     Ratio    95% CI     value
Primary Outcome
                                  2.6      3.2    0.79    0.55-1.13   0.19
Death/MI/Stroke/Renal Failure
Components
  Death                           2.1      2.3    0.87    0.58-1.31
  Stroke                          0.5      0.6    0.83    0.36-1.92

  Non Fatal MI                    0.2      0.4    0.50    0.15-1.65

  New Renal Failure               0.1      0.2    0.50    0.09—2.71




                                                                              17
Other Outcomes between
                     31 days and 1 Year
                           Off Pump On Pump   Hazard
                                                        95% CI     p value
                               %       %       Ratio

Cardiovascular Mortality     1.5      1.5      1.06    0.65-1.73    0.82

Angina                       0.8      0.7      1.13    0.56-2.26    0.74

PCI                          0.7      0.6      1.15    0.55-2.41    0.72

Re-do CABG                   <0.1      0                            0.99

PCI/Re-do CABG               0.7      0.6      1.22    0.59-2.54    0.59




                                                                           18
Quality of Life




                  19
Neurocognitive Function




                          20
Subgroups (1)




                21
Subgroups (2)




                22
Conclusions
• At 1 Year there was no difference between Off
  pump CABG and On pump CABG:

  – Primary Outcome
  – Individual components of the Primary Outcome
  – Revascularization procedures
  – Quality of Life
  – Neurocognitive functions

                                                   23
Implications


• In experienced hands, both procedures are
  reasonable options based on mid-term
  results




                                              24
Steering Committees
A. Lamy (Co-PI)        P.J. Devereaux   J. Murkin
D.P. Taggart           D. Prabhakaran   R.J. Novick
A.R. Akar              S.E. Fremes      E. Paolasso
A. Avezum              S. Hu            L. Piegas
R. Cartier             F. Lanas         Z. Straka
S. Chocron             P.J. Lopez       S. Yusuf (co-PI)




                                                           25
Final Recruitment by Country
      4752 patients from 79 sites in 19 countries
                           Netherlands (27)
                             Sweden (56)
                         United Kingdom (227)
 Canada (830)
                              France (4)        Czech Republic (298)
                               Italy (48)           Estonia (91)
                                                    Turkey (132)
     USA (68)                                       Ukraine (11)
                                                                       China (781)


                                                           India (1307)


    Colombia (57)

                       Brazil (358)


                                                                                     Australia (29)
       Chile (137)        Uruguay (34)

                     Argentina (257)




                                                                                                      26
27

Contenu connexe

Tendances

Tendances (7)

CYTX Cardiac Cell Therapy Panel Presentation at Biotech Showcase
CYTX Cardiac Cell Therapy Panel Presentation at Biotech ShowcaseCYTX Cardiac Cell Therapy Panel Presentation at Biotech Showcase
CYTX Cardiac Cell Therapy Panel Presentation at Biotech Showcase
 
Cohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCICohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCI
 
Iora Health
Iora HealthIora Health
Iora Health
 
Mann T 201110
Mann T 201110Mann T 201110
Mann T 201110
 
Rosuvastatina disminuye la incidencia de nefropatía por contraste en paciente...
Rosuvastatina disminuye la incidencia de nefropatía por contraste en paciente...Rosuvastatina disminuye la incidencia de nefropatía por contraste en paciente...
Rosuvastatina disminuye la incidencia de nefropatía por contraste en paciente...
 
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
 
Benchmarks in Thought Leader Management
Benchmarks in Thought Leader ManagementBenchmarks in Thought Leader Management
Benchmarks in Thought Leader Management
 

En vedette

En vedette (11)

Posible beneficio de la esplerenona en pacientes con infarto agudo de miocard...
Posible beneficio de la esplerenona en pacientes con infarto agudo de miocard...Posible beneficio de la esplerenona en pacientes con infarto agudo de miocard...
Posible beneficio de la esplerenona en pacientes con infarto agudo de miocard...
 
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
 
DEFLECT I: dispositivo de protección cerebral en TAVI
DEFLECT I: dispositivo de protección cerebral en TAVIDEFLECT I: dispositivo de protección cerebral en TAVI
DEFLECT I: dispositivo de protección cerebral en TAVI
 
CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímer...
CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímer...CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímer...
CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímer...
 
Quirofano hibrido por Dr. Gerardo Sela.
Quirofano hibrido por Dr.  Gerardo Sela.Quirofano hibrido por Dr.  Gerardo Sela.
Quirofano hibrido por Dr. Gerardo Sela.
 
Curso Taller De Hemodinamica Y Cardiologia Intervencionista
Curso Taller De Hemodinamica Y Cardiologia IntervencionistaCurso Taller De Hemodinamica Y Cardiologia Intervencionista
Curso Taller De Hemodinamica Y Cardiologia Intervencionista
 
Anatomía coronaria básica - Coronariografía. Visualización de las arterias co...
Anatomía coronaria básica - Coronariografía. Visualización de las arterias co...Anatomía coronaria básica - Coronariografía. Visualización de las arterias co...
Anatomía coronaria básica - Coronariografía. Visualización de las arterias co...
 
Hemodinamia
Hemodinamia Hemodinamia
Hemodinamia
 
Descripción de la Sala de Hemodinamia
Descripción de la Sala de HemodinamiaDescripción de la Sala de Hemodinamia
Descripción de la Sala de Hemodinamia
 
Hemodinamia
HemodinamiaHemodinamia
Hemodinamia
 
Hemodinamia
HemodinamiaHemodinamia
Hemodinamia
 

Similaire à Revascularización miocárdica sin bomba; iguales resultados al año que la cirugía con bomba

Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)
escts2012
 
Accord blood pressure (cushman)
Accord blood pressure (cushman)Accord blood pressure (cushman)
Accord blood pressure (cushman)
Trimed Media Group
 
Implications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practiceImplications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practice
Trimed Media Group
 
Pfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care ConferencePfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care Conference
finance5
 
Trial to assess chelation therapy (tact) slides
Trial to assess chelation therapy (tact) slidesTrial to assess chelation therapy (tact) slides
Trial to assess chelation therapy (tact) slides
Marilyn Mann
 

Similaire à Revascularización miocárdica sin bomba; iguales resultados al año que la cirugía con bomba (20)

Aha lbct
Aha lbctAha lbct
Aha lbct
 
CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results
 
Hamon M_2 201111
Hamon M_2 201111Hamon M_2 201111
Hamon M_2 201111
 
Off-pump versus in-pump CABG in high-risk patients
Off-pump versus in-pump CABG in high-risk patientsOff-pump versus in-pump CABG in high-risk patients
Off-pump versus in-pump CABG in high-risk patients
 
Medical Sample 23
Medical  Sample 23Medical  Sample 23
Medical Sample 23
 
Ischemia Trial
Ischemia TrialIschemia Trial
Ischemia Trial
 
Dmt g pday_oct12
Dmt g pday_oct12Dmt g pday_oct12
Dmt g pday_oct12
 
Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)
 
Accord blood pressure (cushman)
Accord blood pressure (cushman)Accord blood pressure (cushman)
Accord blood pressure (cushman)
 
Estenosis Carotidea en paciente con Cardiopatía Isquémica
Estenosis Carotidea en paciente con Cardiopatía IsquémicaEstenosis Carotidea en paciente con Cardiopatía Isquémica
Estenosis Carotidea en paciente con Cardiopatía Isquémica
 
Acromegal
AcromegalAcromegal
Acromegal
 
Emmanouil S. Brilakis - CTO PCI Outcome associated with poor quality of the d...
Emmanouil S. Brilakis - CTO PCI Outcome associated with poor quality of the d...Emmanouil S. Brilakis - CTO PCI Outcome associated with poor quality of the d...
Emmanouil S. Brilakis - CTO PCI Outcome associated with poor quality of the d...
 
MI-TLIF - effect of Age, BMI & Comorbidity - 2012-10-06 - SA Neurosurgery Con...
MI-TLIF - effect of Age, BMI & Comorbidity - 2012-10-06 - SA Neurosurgery Con...MI-TLIF - effect of Age, BMI & Comorbidity - 2012-10-06 - SA Neurosurgery Con...
MI-TLIF - effect of Age, BMI & Comorbidity - 2012-10-06 - SA Neurosurgery Con...
 
S cárdio renal
S cárdio renalS cárdio renal
S cárdio renal
 
Whelton sprint(1)
Whelton sprint(1)Whelton sprint(1)
Whelton sprint(1)
 
Randil
RandilRandil
Randil
 
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
 
Implications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practiceImplications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practice
 
Pfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care ConferencePfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care Conference
 
Trial to assess chelation therapy (tact) slides
Trial to assess chelation therapy (tact) slidesTrial to assess chelation therapy (tact) slides
Trial to assess chelation therapy (tact) slides
 

Plus de Sociedad Latinoamericana de Cardiología Intervencionista

Plus de Sociedad Latinoamericana de Cardiología Intervencionista (20)

POLAR ACS: plataforma bio absorbible en síndromes coronarios agudos
POLAR ACS: plataforma bio absorbible en síndromes coronarios agudosPOLAR ACS: plataforma bio absorbible en síndromes coronarios agudos
POLAR ACS: plataforma bio absorbible en síndromes coronarios agudos
 
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
ELISA 3: estrategia invasiva precoz vs tardía en pacientes sin supra desnivel...
 
THRIVE: La niacina / laropiprant de liberación prolongada. Beneficio cardiova...
THRIVE: La niacina / laropiprant de liberación prolongada. Beneficio cardiova...THRIVE: La niacina / laropiprant de liberación prolongada. Beneficio cardiova...
THRIVE: La niacina / laropiprant de liberación prolongada. Beneficio cardiova...
 
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
 
Reestenosis intrastent farmacológico con balón farmacológico
Reestenosis intrastent farmacológico con balón farmacológico Reestenosis intrastent farmacológico con balón farmacológico
Reestenosis intrastent farmacológico con balón farmacológico
 
Tromboaspiración: resistencia de la microcirculación
Tromboaspiración: resistencia de la microcirculaciónTromboaspiración: resistencia de la microcirculación
Tromboaspiración: resistencia de la microcirculación
 
Stent liberador de sirolimus vs everolimus en bifurcaciones
Stent liberador de sirolimus vs everolimus en bifurcacionesStent liberador de sirolimus vs everolimus en bifurcaciones
Stent liberador de sirolimus vs everolimus en bifurcaciones
 
¿Qué métodos han confirmado su eficacia para prevenir la nefropatía inducida ...
¿Qué métodos han confirmado su eficacia para prevenir la nefropatía inducida ...¿Qué métodos han confirmado su eficacia para prevenir la nefropatía inducida ...
¿Qué métodos han confirmado su eficacia para prevenir la nefropatía inducida ...
 
BVS for BTK
BVS for BTKBVS for BTK
BVS for BTK
 
Antiplaquetarios en el síndrome coronario agudo
Antiplaquetarios en el síndrome coronario agudoAntiplaquetarios en el síndrome coronario agudo
Antiplaquetarios en el síndrome coronario agudo
 
Polymer-Free DES
Polymer-Free DESPolymer-Free DES
Polymer-Free DES
 
Drug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCIDrug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCI
 
The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarct...
The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarct...The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarct...
The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarct...
 
Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Ho...
Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Ho...Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Ho...
Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Ho...
 
Cangrelor compared with clopidogrel improves efficiency without increasing bl...
Cangrelor compared with clopidogrel improves efficiency without increasing bl...Cangrelor compared with clopidogrel improves efficiency without increasing bl...
Cangrelor compared with clopidogrel improves efficiency without increasing bl...
 
Angioplastias electivas: se pueden realizar en Hospitales con o sin soporte q...
Angioplastias electivas: se pueden realizar en Hospitales con o sin soporte q...Angioplastias electivas: se pueden realizar en Hospitales con o sin soporte q...
Angioplastias electivas: se pueden realizar en Hospitales con o sin soporte q...
 
Oclusión de la orejuela izquierda vs anticoagulación con Warfarina para preve...
Oclusión de la orejuela izquierda vs anticoagulación con Warfarina para preve...Oclusión de la orejuela izquierda vs anticoagulación con Warfarina para preve...
Oclusión de la orejuela izquierda vs anticoagulación con Warfarina para preve...
 
Boletim 81, Novembro 2012 - Programa Educativo PROEDUCAR SOLACI
Boletim 81, Novembro 2012 - Programa Educativo PROEDUCAR SOLACIBoletim 81, Novembro 2012 - Programa Educativo PROEDUCAR SOLACI
Boletim 81, Novembro 2012 - Programa Educativo PROEDUCAR SOLACI
 
Boletim 79, Setembro 2012 - Programa Educativo PROEDUCAR SOLACI
Boletim 79, Setembro 2012 - Programa Educativo PROEDUCAR SOLACIBoletim 79, Setembro 2012 - Programa Educativo PROEDUCAR SOLACI
Boletim 79, Setembro 2012 - Programa Educativo PROEDUCAR SOLACI
 
Boletin 80, Octubre 2012 - Programa Educativo PROEDUCAR SOLACI
Boletin 80, Octubre 2012 - Programa Educativo PROEDUCAR SOLACIBoletin 80, Octubre 2012 - Programa Educativo PROEDUCAR SOLACI
Boletin 80, Octubre 2012 - Programa Educativo PROEDUCAR SOLACI
 

Dernier

👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
Sheetaleventcompany
 
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
dishamehta3332
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Sheetaleventcompany
 
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Sheetaleventcompany
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Sheetaleventcompany
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
Sheetaleventcompany
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Sheetaleventcompany
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Sheetaleventcompany
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
Sheetaleventcompany
 

Dernier (20)

Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
 
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
 
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
 
tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacytongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacy
 
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
 
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
 
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
 
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
 
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 

Revascularización miocárdica sin bomba; iguales resultados al año que la cirugía con bomba

  • 1. CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study Results at 1 Year André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures: CORONARY was funded by a grant from the Canadian Institutes of Health Research (CIHR).
  • 2. Background • Benefits and risks of performing CABG surgery on beating heart (off pump) not clearly established. • Meta-analyses of 59 trials involving 8961 pts – No differences in major CV outcomes except strokes • ROOBY (1 Year) – Primary Outcome: Off-pump is worse (p=0.04) – CV Deaths: Off-pump is worse (p=0.03) 2
  • 3. CORONARY Trial Organization • 79 centers in 19 countries • 4,752 patients recruited between (November 2006 October 2011) • Designed, coordinated, managed and data analysed and reported by the Population Health Research Institute, Hamilton Health Sciences and McMaster University in Hamilton, Canada • The data was monitored by independent DSMB • Funded by Canadian Institutes of Health Research 3
  • 4. Inclusion/Exclusion Criteria • Inclusion Criteria – Isolated CABG with median sternotomy – One of the following: 1. Peripheral vascular disease 2. Cerebrovascular disease 3. Renal Insufficiency 4. Age ≥ 70 years 5. Age 60 -69 with at least one risk factor (diabetes, urgent revascularization, smoker, LVEF ≤ 35%) 6. Age 55 -59 with at least two of the above risk factors • Exclusions – Additional cardiac procedure planned – Contraindications to off-pump or on-pump CABG – Emergency or re-do CABG 5
  • 5. Qualifications of Surgeons • Surgical expertise-based randomization – > 2 years of experience as staff cardiac surgeon and – > 100 cases of one or both techniques – Trainees were not allowed to be primary operators 6
  • 6. Primary Outcomes • 1st Co-Primary Outcome Composite of total mortality, stroke, non fatal myocardial infarction, new renal failure at 30 days post randomization results presented ACC 2012 results at 1 year • 2nd Co-Primary Outcome Composite of above outcomes plus repeat coronary revascularization over 5 yrs of follow-up (expected 2016) 7
  • 7. Baseline Characteristics OFF-PUMP ON-PUMP (n = 2375) (n = 2377) Mean Age (years) 67.6 67.5 Males (%) 80.0 81.7 Prior MI 33.8 35.2 Previous Stroke 6.7 7.8 Peripheral Arterial Disease 8.0 8.2 Congestive Heart Failure 5.9 6.6 Urgent Surgery 39.5 38.1 Euroscore 0–2 28.6 27.8 3–5 51.7 54.2 > 5 18.1 16.8 10
  • 8. Baseline Disease – Pre-op Angiogram OFF-PUMP ON-PUMP (n = 2375) (n = 2377) % % Left Main 22.1 20.9 Triple Vessel 56.1 60.4 Double Vessel 18.7 16.4 Single Vessel 3.0 2.1 11
  • 9. 1st Co-Primary Outcome (1 Year) Off Pump On Pump Hazard p % % Ratio 95% CI value Primary Outcome 12.1 13.3 0.91 0.77-1.07 0.24 Death, Stroke, MI, Renal Failure Components Death 5.1 5.0 1.03 0.80-1.32 Stroke 1.5 1.7 0.90 0.57-1.41 Non Fatal MI 6.8 7.5 0.90 0.73-1.12 New Renal Failure 1.3 1.3 0.97 0.59-1.60 14
  • 10. Death/MI/Stroke/New Renal Failure 0.20 0.15 at 1 Year On Pump CABG Cumulative Event Rate Off Pump CABG 0.10 HR 0.91 0.05 95% CI 0.77-1.07 p value 0.24 0.0 0 3 6 9 12 15
  • 11. Other Outcomes at 1 year Off Pump On Pump Hazard 95% CI p value % % Ratio Cardiovascular Mortality 4.2 4.0 1.03 0.78-1.37 0.83 Angina 1.0 0.9 1.05 0.58-1.88 0.87 PCI 1.1 0.8 1.43 0.79-2.57 0.23 Re-do CABG 0.3 0.04 7.00 0.86-57.0 0.07 PCI/Re-do CABG 1.4 0.8 1.66 0.95-2.89 0.07 Primary Outcome per Protocol 11.5 13.2 0.86 0.73-1.02 0.08 16
  • 12. Primary Outcome between 31 days and 1 Year Off Pump On Pump Hazard p % % Ratio 95% CI value Primary Outcome 2.6 3.2 0.79 0.55-1.13 0.19 Death/MI/Stroke/Renal Failure Components Death 2.1 2.3 0.87 0.58-1.31 Stroke 0.5 0.6 0.83 0.36-1.92 Non Fatal MI 0.2 0.4 0.50 0.15-1.65 New Renal Failure 0.1 0.2 0.50 0.09—2.71 17
  • 13. Other Outcomes between 31 days and 1 Year Off Pump On Pump Hazard 95% CI p value % % Ratio Cardiovascular Mortality 1.5 1.5 1.06 0.65-1.73 0.82 Angina 0.8 0.7 1.13 0.56-2.26 0.74 PCI 0.7 0.6 1.15 0.55-2.41 0.72 Re-do CABG <0.1 0 0.99 PCI/Re-do CABG 0.7 0.6 1.22 0.59-2.54 0.59 18
  • 18. Conclusions • At 1 Year there was no difference between Off pump CABG and On pump CABG: – Primary Outcome – Individual components of the Primary Outcome – Revascularization procedures – Quality of Life – Neurocognitive functions 23
  • 19. Implications • In experienced hands, both procedures are reasonable options based on mid-term results 24
  • 20. Steering Committees A. Lamy (Co-PI) P.J. Devereaux J. Murkin D.P. Taggart D. Prabhakaran R.J. Novick A.R. Akar S.E. Fremes E. Paolasso A. Avezum S. Hu L. Piegas R. Cartier F. Lanas Z. Straka S. Chocron P.J. Lopez S. Yusuf (co-PI) 25
  • 21. Final Recruitment by Country 4752 patients from 79 sites in 19 countries Netherlands (27) Sweden (56) United Kingdom (227) Canada (830) France (4) Czech Republic (298) Italy (48) Estonia (91) Turkey (132) USA (68) Ukraine (11) China (781) India (1307) Colombia (57) Brazil (358) Australia (29) Chile (137) Uruguay (34) Argentina (257) 26
  • 22. 27